In a failing heart, FGF-21 exerts protective effects, preventing the development of cardiac hypertrophy and ischemic injury via the Sirt1 (sirtuin-1) pathway [85, 89]. The gene discussed is SIRT1; the disease is cardiac hypertrophy.